Teva Pharma (TEVA) PT Lowered to $20 at RBC Capital

February 14, 2019 6:50 AM EST Send to a Friend

RBC Capital analyst Randall Stanicky ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Teva Pharma (TEVA) PT Lowered to $20 at RBC Capital

Member Login

Free News Feed